Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy

Maurer, M. S., Judge, D. P., Gillmore, J. D., Garcia-Pavia, P., Masri, A., Cappelli, F., Alexander, K. M., Sarswat, N., Grogan, M., Ambardekar, A. V., Ducharme, A., Poulsen, S. H., Lam, K., Obici, L., Soman, P., Rao, S., Tamby, J.-F., Castaño, A., Fox, J. C., … Fontana, M. (2025). Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy. Journal of the American College of Cardiology, 85(20), 1911–1923. https://doi.org/10.1016/j.jacc.2025.03.542
Authors:
Mathew S Maurer
Daniel P Judge
Julian D Gillmore
Pablo Garcia-Pavia
Ahmad Masri
Francesco Cappelli
Kevin M Alexander
Nitasha Sarswat
Martha Grogan
Amrut V Ambardekar
Anique Ducharme
Steen H Poulsen
Kaitlyn Lam
Laura Obici
Prem Soman
Satish Rao
Jean-François Tamby
Adam Castaño
Jonathan C Fox
Brian Adam
Surendhar Reddy Chepyala
Bill Poland
Uma Sinha
Marianna Fontana
Affiliated Authors:
Mathew S Maurer
Author Keywords:
acoramid is
all-cause mortality
attr-cm
serum ttr
transthyretin
ttr stabilization
acoramidis
Publication Type:
Article
Unique ID:
10.1016/j.jacc.2025.03.542
PMID:
Publication Date:
Data Source:
PubMed

Record Created: